title: Insulin analogue usage in a haemodialysis patient with type 2 diabetes mellitus.
authors.forename: Alpaslan
authors.initials: A
authors.lastname: Ersoy
authors.forename: Canan
authors.initials: C
authors.lastname: Ersoy
authors.forename: Tumay
authors.initials: T
authors.lastname: Altinay
mesh_terms: D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007328:Insulin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000069036:Insulin Glargine; D061268:Insulin Lispro; D049528:Insulin, Long-Acting; D007676:Kidney Failure, Chronic / Q000150:complications / Q000628:therapy; D008875:Middle Aged; D006435:Renal Dialysis
chemical_list: D007004:Hypoglycemic Agents; D007328:Insulin; D061268:Insulin Lispro; D049528:Insulin, Long-Acting; D000069036:Insulin Glargine